Abstract
Cancer is the second leading cause of death worldwide, and early detection, associated with an appropriate therapeutic regimen, is the best option to substantially reduce the risk of mortality. Despite advances in the study of biomarkers for diagnosis, strategies for their detection still require improvements both in the selectivity of capturing circulating tumor cells (CTCs) and in the s…